BBAI-WT — BigBear.ai Holdings, Inc.

NYSE · Information Technology · Software · CIK 1836981 ·
Last close
$0.19
Market Cap
52W High
$0.24
52W Low
$0.19
ADV30
81,511
Next earnings
Semnur Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its lead product candidate is SP-102, a novel viscous gel formulation of corticosteroid to treat lumbosacral radicular pain, or sciatica, which is in the second Phase 3 study. The company was founded in 2013 and is headquartered in Palo Alto, California. Semnur Pharmaceuticals, Inc. operates as a subsidiary of Scilex Holding Company.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2024 41,505,000 10,766,000 -10,539,000 -15,135,000 343,776,000 50,141,000 347,490,000

Annual Trend (SEC EDGAR, last 1y)

Revenues vs Net Income (last 1y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2024 155,164,000 -39,034,000 -70,657,000 343,776,000 347,490,000

TTM Snapshot

Revenues TTM
$41,505,000
NetIncome TTM
$-15,135,000
OpCashFlow TTM
$0
Assets (Latest)
$343,776,000
Forward EPS

Peers — same industry

TickerNameMarket CapLastDaily %
MSFT MICROSOFT CORP $2.86T $385.10
ORCL ORACLE CORP $405.11B $140.64
PLTR Palantir Technologies Inc. $291.12B $126.79
CRWD CrowdStrike Holdings, Inc. $190.60B $187.18
SAP SAP SE $184.31B $157.86

Recent Insider Activity

No insider activity indexed for this ticker.